What is intramuscular vs subcutaneous injection?
Intramuscular injection (IM) delivers medication into muscle tissue using a longer needle, while subcutaneous injection (SC) deposits it in the fat layer beneath the skin with a shorter needle. Both are used for testosterone replacement therapy with different absorption rates and administration schedules.
Intramuscular and subcutaneous injections differ primarily in needle depth and target tissue. Intramuscular (IM) injection uses a longer needle (typically 1 to 1.5 inches) to penetrate through skin and fat into the muscle layer below, most commonly in the glutes, deltoids, or quads. Subcutaneous (SC) injection uses a shorter needle (about 0.5 inches) to deposit medication in the fatty tissue just beneath the skin, usually on the abdomen or thigh.
The two methods produce different absorption profiles. Intramuscular injection generally provides faster initial absorption and longer intervals between doses, making it practical for weekly or bi-weekly testosterone protocols. Subcutaneous injection releases testosterone more gradually, which can reduce hormone level fluctuations and suit patients preferring more frequent, smaller doses. Some individuals report less discomfort with subcutaneous administration due to the smaller needle gauge.
TRT clinics select between these methods based on patient tolerance, dosing strategy, and treatment goals. Intramuscular remains the traditional standard for testosterone cypionate and enanthate, while subcutaneous has gained traction for patients seeking flexibility and those with needle anxiety. Both methods are FDA-approved for testosterone replacement. Your provider at a hormone therapy clinic will recommend the injection type that aligns with your specific protocol and comfort level.